Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FTC still going after ephedra

This article was originally published in The Tan Sheet

Executive Summary

Three related supplement companies have been engaged in deceptive advertising practices, according to a Nov. 10 complaint filed by FTC. The defendants are cited for claiming Thermalean combines the weight-loss benefits of three different prescription drugs and Lipodrene has been clinically proven to cause substantial and safe weight loss, FTC announces Nov. 30. Both products contained ephedra, but have not been marketed or sold since FDA banned the botanical earlier this year. Four of the defendants - Jared Wheat, Hi-Tech Pharmaceuticals, National Urological Group and National Institute for Clinical Weight Loss - were named in an FDA consent decree in October 2003 that barred defendants from selling certain erectile dysfunction and obesity supplements (1"The Tan Sheet" Oct. 13, 2003, p. 4)...
Advertisement

Related Content

Dietary Supplement Obesity, Erectile Dysfunction Claims Barred By Court
Dietary Supplement Obesity, Erectile Dysfunction Claims Barred By Court

Topics

Advertisement
UsernamePublicRestriction

Register

PS097593

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel